HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 70 filers reported holding HARPOON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $175,000 | -33.7% | 12,636 | 0.0% | 0.00% | – |
| Q1 2021 | $264,000 | -13.2% | 12,636 | -31.3% | 0.00% | -100.0% |
| Q4 2020 | $304,000 | -50.0% | 18,386 | -48.9% | 0.00% | 0.0% |
| Q3 2020 | $608,000 | +57.5% | 35,973 | +54.1% | 0.00% | 0.0% |
| Q2 2020 | $386,000 | +53.8% | 23,337 | +7.1% | 0.00% | 0.0% |
| Q1 2020 | $251,000 | -20.3% | 21,781 | +2.6% | 0.00% | 0.0% |
| Q4 2019 | $315,000 | – | 21,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |